Zhengchuan Pharmapack(603976)2024-11-29 07:35Group 1: Financial Performance - The company's revenue decreased compared to the same period last year, but profit increased, primarily due to the growth in sales of boron products [3] - The gross profit margin has rebounded significantly [3] Group 2: Convertible Bonds - The company has issued 405 million yuan in convertible bonds, which have not yet been converted, with over 2 years remaining until maturity [3] - The company is considering how to promote the conversion of these bonds [3] Group 3: Market Value Management - The company will continue to enhance its operational capabilities and improve intrinsic value to provide better returns to investors [4] - The company plans to strengthen communication with investors through various channels, including performance briefings and analyst meetings, in line with the latest market value management guidelines [4]